Fetal Tumors: Does Intrauterine Transfusion Help?

Fetal Tumors: Does Intrauterine Transfusion Help?

Managing high-risk pregnancies involves understanding intrauterine transfusion outcomes when dealing with complex fetal tumors. These tumors often cause severe anemia, necessitating urgent intervention to prevent fetal demise. Consequently, a systematic review recently analyzed the efficacy of intrauterine transfusion (IUT) in such challenging scenarios. Researchers evaluated 43 cases to determine how IUT impacts survival.

Factors Affecting Intrauterine Transfusion Outcomes

Interestingly, most cases presented with additional non-structural complications at baseline. For instance, clinicians observed fetal hydrops or cardiomegaly in several patients. These conditions significantly increased the risk of perinatal death. Furthermore, the data showed that higher hemoglobin levels after the first transfusion improved survival chances.

Clinical Findings and Survival Rates

The study highlighted that preterm birth occurred in over 80% of cases. Although clinicians often performed tumor resection alongside IUT, the management strategy did not drastically alter the perinatal death rate. Therefore, selecting the right candidates for standalone therapy remains a priority for fetal medicine specialists. Clinicians should monitor these pregnancies closely due to the high risk of obstetric complications. Finally, the results suggest that IUT is a viable option for managing fetal anemia.

Frequently Asked Questions

Q1: What are the main risks associated with fetal tumors and anemia?

Fetal tumors can cause severe anemia, leading to hydrops or heart failure. These conditions often result in preterm birth or perinatal death if left untreated.

Q2: How does intrauterine transfusion improve outcomes?

Intrauterine transfusion replaces lost red blood cells, which stabilizes the fetus. Higher post-procedure hemoglobin levels are strongly associated with a lower likelihood of perinatal death.

References

1. Schenone CV et al. Perinatal outcomes following intrauterine transfusion for fetal anemia secondary to fetal or placental tumor: systematic review. Ultrasound Obstet Gynecol. 2026 May 03. doi: 10.1002/uog.70234. PMID: 42070963.
2. Devlieger R et al. Intrauterine transfusion: Best practices, techniques, and evolving trends. Best Pract Res Clin Obstet Gynaecol. 2026 Feb;104:102686. doi: 10.1016/j.bpobgyn.2025.102686.
3. Prefumo F et al. Fetal anemia: Diagnosis and management. Best Pract Res Clin Obstet Gynaecol. 2019 May;58:2-14. doi: 10.1016/j.bpobgyn.2019.01.001.